The 2009 ASCO (American Society of Clinical Oncology) Electronic Health Record (EHR) symposium is this October in San Francisco, CA. Because of the HITECH provisions found in the ARRA, we know that EHRs will become very prevalent across all medical specialties, including oncology.
In the field of oncology, so many medications cause significant adverse reactions. Plus, combination therapy is often used to treat cancer. EHRs can help clinicians keep track of all the treatment infusions and they may also alert providers about the possible risks associated with combining certain chemotherapy agents with targeted biologics.
Interested in knowing who will be speaking? Here are just a few examples:
- Peter Yu, M.D. - Chair ASCO EHR Workgroup, Oncologist, Palo Alto Medical Foundation (PAMF)
- Barbara McAneny, M.D. - CEO, New Mexico Oncology Hematology Consultants
- Charles McKay, M.D. - CEO, Tennessee Oncology
- John Cox, D.O., M.B.A. - Editor-in-Chief, Journal of Oncology Practice
- Robert Miller, M.D. - Oncologist, Johns Hopkins Kimmel Cancer Center
- Kenneth Buetow, Ph.D. - Director, NCI's Center for Biomedical Informatics and Information Technology (CBIIT)
- Lawrence Shulman, M.D. - Chief Medical Officer, Dana- Farber Cancer Center
- William Hersh, M.D. - Chair, Department of Medical Information and Clinical Epidemiology, Oregon Health and Sciences University